Skip to main content
Clinical Trials/NCT04914000
NCT04914000
Completed
Not Applicable

Motivating a Spectrum of Cancer Patients to Quit Smoking: Intervention Development and Feasibility

H. Lee Moffitt Cancer Center and Research Institute1 site in 1 country53 target enrollmentJune 14, 2021
ConditionsCancerSmoking

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Enrollment
53
Locations
1
Primary Endpoint
Number of Participants Who Read the Booklet - Demand - 1 Week Post Treatment
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study will assess feasibility and acceptability of an intervention designed to increase smoking cessation motivation among patients with a cancer not widely known to be smoking related.

Registry
clinicaltrials.gov
Start Date
June 14, 2021
End Date
June 2, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Smoking at least 1 cigarette in previous 30 days
  • Diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer within the last 6 months
  • Able to read/write English
  • Able to give informed consent
  • Not currently enrolled in a smoking cessation program

Exclusion Criteria

  • Having distant metastases
  • Male patients with breast cancer

Outcomes

Primary Outcomes

Number of Participants Who Read the Booklet - Demand - 1 Week Post Treatment

Time Frame: 1-week post-treatment

Number of study participants who read the booklet

Number of Participants Who Read the Booklet - Demand - 1 Month Post Treatment

Time Frame: 1-month post-treatment

Number of study participants who read the booklet

Number of Participants That Complete 1-week Follow-up Assessments - Feasibility

Time Frame: 1-week post-treatment

Number of participants who complete 1-week follow-up assessments

Number of Participants That Complete 1 Month Follow-up Assessments - Feasibility

Time Frame: 1-month post-treatment

Number of participants who complete 1-month follow-up assessments

Number of Participants Who Consent to Participate in the Study- Feasibility

Time Frame: Baseline

Number of participants who consent to participate in the study

Acceptability

Time Frame: 1-month post-treatment

Treatment satisfaction measured with 8 items adapted from the Client Satisfaction Questionnaire, values between 8 and 32, with higher scores mean a better outcome.

Secondary Outcomes

  • Participants Change in Motivation - Action Stage(Baseline, at 1 week and 1 month post treatment)
  • Number of Participants Reporting 7-day Point Prevalence Abstinence(1-week post-treatment)
  • Number of Participants Reporting 30-day Point Prevalence Abstinence(1-month post-treatment)
  • Motivation to Quit Smoking Assessed With the Contemplation Ladder(Baseline, 1-week post-treatment, 1-month post-treatment)
  • Motivation to Quit Smoking Assessed With the Short Form of the Smoking Abstinence-related Motivational Engagement (ARME).(Baseline, 1-week post-treatment, 1-month post-treatment)
  • Motivation to Quit Smoking Assessed With the Number of Visits to the Study Website(1-month post-treatment)
  • Motivation to Quit Smoking Assessed by Contact With the Tobacco Treatment Specialist - 1 Month(At 1 Month Post Treatment)
  • Participants That Had a Quit Attempt - 1 Week(At 1 Week Post Treatment)
  • Participants That Had a Quit Attempt - 1 Month(At 1 Month Post Treatment)
  • Motivation to Quit Smoking Assessed With the Number of Quit Attempts - 1 Month(At 1 Month Post Treatment)
  • Motivation to Quit Smoking Assessed by Contact With the Tobacco Treatment Specialist - 1 Week(At 1 Week Post Treatment)

Study Sites (1)

Loading locations...

Similar Trials